Insulin glargine and lixisenatide Subcutaneous and Synthamin 17
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Synthamin 17 and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: parenteral nutrition solution
Brand name: AminoProtect, Aminosyn II, Aminosyn II/Electrolytes, Aminosyn M, Aminosyn, Aminosyn-HBC, Aminosyn-PF, Aminosyn-RF, Aminosyn/Electrolytes, Clinimix E/Dextrose, Clinimix N14G30E, Clinimix N9G15E, Clinimix N9G20E, Clinimix/Dextrose, Clinisol SF, FreAmine HBC, FreAmine III, Hepatamine, NephrAmine, Plenamine, Premasol, Prosol, Synthamin 17, Travasol, TrophAmine, TrophAmine
Synonyms: Amino Acid Injection
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Synthroid
- Insulin glargine and lixisenatide Subcutaneous-Synthroid Injection
- Insulin glargine and lixisenatide Subcutaneous-Syntocinon
- Insulin glargine and lixisenatide Subcutaneous-Synvexia (Lidocaine and Menthol Cream)
- Insulin glargine and lixisenatide Subcutaneous-Synvexia (Lidocaine and Menthol Patch)
- Insulin glargine and lixisenatide Subcutaneous-Synvexia Patch
- Synthamin 17-Insulin glargine, recombinant Subcutaneous
- Synthamin 17-Insulin glulisine
- Synthamin 17-Insulin Glulisine (Cartridges and Pens)
- Synthamin 17-Insulin Glulisine (Vials)
- Synthamin 17-Insulin glulisine Subcutaneous
- Synthamin 17-Insulin human inhaled Inhalation